N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide

C115H123N19O20S5 — CID 161266915

IUPACN-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide
SMILESCc1cc(C(=O)NO)ccc1N1CCC(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)CC1.O=C(CO)c1cnc(N2CCC(CNS(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(CO)c1cnc(N2CCC(CNS(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(CO)c1cnc(N2CCC(NS(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(NO)c1ccc(N2CCC(NS(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1
InChIInChI=1S/C25H27N3O4S.C24H26N4O4S.C23H24N4O4S.C22H24N4O4S.C21H22N4O4S/c1-18-17-21(25(29)26-30)9-12-24(18)28-15-13-22(14-16-28)27-33(31,32)23-10-7-20(8-11-23)19-5-3-2-4-6-19;29-17-23(30)21-15-25-24(26-16-21)28-12-10-18(11-13-28)14-27-33(31,32)22-8-6-20(7-9-22)19-4-2-1-3-5-19;28-23(25-29)19-8-11-22(24-16-19)27-14-12-20(13-15-27)26-32(30,31)21-9-6-18(7-10-21)17-4-2-1-3-5-17;27-15-21(28)19-13-23-22(24-14-19)26-9-7-16(8-10-26)12-25-31(29,30)20-6-5-17-3-1-2-4-18(17)11-20;26-14-20(27)17-12-22-21(23-13-17)25-9-7-18(8-10-25)24-30(28,29)19-6-5-15-3-1-2-4-16(15)11-19/h2-12,17,22,27,30H,13-16H2,1H3,(H,26,29);1-9,15-16,18,27,29H,10-14,17H2;1-11,16,20,26,29H,12-15H2,(H,25,28);1-6,11,13-14,16,25,27H,7-10,12,15H2;1-6,11-13,18,24,26H,7-10,14H2
InChIKeyVDHPLRCZMHCBJV-UHFFFAOYSA-N
MW2251.70 g/mol
LogP12.81
Rot. Bonds33

About N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide

N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide (PubChem CID 161266915) has the molecular formula C115H123N19O20S5 and a molecular weight of 2251.70 g/mol. Its IUPAC name is N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide.

Molecular Properties

Compound NameN-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide
PubChem CID161266915
Molecular FormulaC115H123N19O20S5
Molecular Weight2251.70 g/mol
Exact Mass2249.78
IUPAC NameN-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide
SMILESCc1cc(C(=O)NO)ccc1N1CCC(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)CC1.O=C(CO)c1cnc(N2CCC(CNS(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(CO)c1cnc(N2CCC(CNS(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(CO)c1cnc(N2CCC(NS(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(NO)c1ccc(N2CCC(NS(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1
InChIInChI=1S/C25H27N3O4S.C24H26N4O4S.C23H24N4O4S.C22H24N4O4S.C21H22N4O4S/c1-18-17-21(25(29)26-30)9-12-24(18)28-15-13-22(14-16-28)27-33(31,32)23-10-7-20(8-11-23)19-5-3-2-4-6-19;29-17-23(30)21-15-25-24(26-16-21)28-12-10-18(11-13-28)14-27-33(31,32)22-8-6-20(7-9-22)19-4-2-1-3-5-19;28-23(25-29)19-8-11-22(24-16-19)27-14-12-20(13-15-27)26-32(30,31)21-9-6-18(7-10-21)17-4-2-1-3-5-17;27-15-21(28)19-13-23-22(24-14-19)26-9-7-16(8-10-26)12-25-31(29,30)20-6-5-17-3-1-2-4-18(17)11-20;26-14-20(27)17-12-22-21(23-13-17)25-9-7-18(8-10-25)24-30(28,29)19-6-5-15-3-1-2-4-16(15)11-19/h2-12,17,22,27,30H,13-16H2,1H3,(H,26,29);1-9,15-16,18,27,29H,10-14,17H2;1-11,16,20,26,29H,12-15H2,(H,25,28);1-6,11,13-14,16,25,27H,7-10,12,15H2;1-6,11-13,18,24,26H,7-10,14H2
InChIKeyVDHPLRCZMHCBJV-UHFFFAOYSA-N
XLogP12.81
TPSA547.84 Ų
H-Bond Donors12
H-Bond Acceptors32
Rotatable Bonds33
Heavy Atoms159
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002251.70
LogP ≤ 512.81
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide?
The IUPAC name of N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide (CID 161266915) is N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide.
What is the SMILES notation for N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide?
The canonical SMILES for N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide is Cc1cc(C(=O)NO)ccc1N1CCC(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)CC1.O=C(CO)c1cnc(N2CCC(CNS(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.O=C(CO)c1cnc(N2CCC(CNS(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(CO)c1cnc(N2CCC(NS(=O)(=O)c3ccc4ccccc4c3)CC2)nc1.O=C(NO)c1ccc(N2CCC(NS(=O)(=O)c3ccc(-c4ccccc4)cc3)CC2)nc1.
What is the InChIKey of N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide?
The InChIKey is VDHPLRCZMHCBJV-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H27N3O4S.C24H26N4O4S.C23H24N4O4S.C22H24N4O4S.C21H22N4O4S/c1-18-17-21(25(29)26-30)9-12-24(18)28-15-13-22(14-16-28)27-33(31,32)23-10-7-20(8-11-23)19-5-3-2-4-6-19;29-17-23(30)21-15-25-24(26-16-21)28-12-10-18(11-13-28)14-27-33(31,32)22-8-6-20(7-9-22)19-4-2-1-3-5-19;28-23(25-29)19-8-11-22(24-16-19)27-14-12-20(13-15-27)26-32(30,31)21-9-6-18(7-10-21)17-4-2-1-3-5-17;27-15-21(28)19-13-23-22(24-14-19)26-9-7-16(8-10-26)12-25-31(29,30)20-6-5-17-3-1-2-4-18(17)11-20;26-14-20(27)17-12-22-21(23-13-17)25-9-7-18(8-10-25)24-30(28,29)19-6-5-15-3-1-2-4-16(15)11-19/h2-12,17,22,27,30H,13-16H2,1H3,(H,26,29);1-9,15-16,18,27,29H,10-14,17H2;1-11,16,20,26,29H,12-15H2,(H,25,28);1-6,11,13-14,16,25,27H,7-10,12,15H2;1-6,11-13,18,24,26H,7-10,14H2.
What are the key properties of N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide?
N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide has a molecular weight of 2251.70 g/mol, XLogP of 12.81, 33 rotatable bonds, 12 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]naphthalene-2-sulfonamide;N-[[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]methyl]-4-phenylbenzenesulfonamide;N-[1-[5-(2-hydroxyacetyl)pyrimidin-2-yl]piperidin-4-yl]naphthalene-2-sulfonamide;N-hydroxy-3-methyl-4-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]benzamide;N-hydroxy-6-[4-[(4-phenylphenyl)sulfonylamino]piperidin-1-yl]pyridine-3-carboxamide is sourced from PubChem (CID 161266915), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).